Schedule 13G ownership disclosure

SORRENTO THERAPEUTICS IN

Security class unavailable · CUSIP: 83587F202

Event date: 2017-04-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-027515
Form type
SC 13G
Filer
Sorrento Therapeutics, Inc.
CIK
CIK 850261
Filed
May 15, 2017
Reporting period
Apr 27, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub